Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Florian Brand
Recent news which mentions Florian Brand
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
August 14, 2024
Tickers
ATAI
Tags
treatment/resistant depression
Florian Brand
Market News
From
Benzinga
Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026
November 14, 2023
Tickers
ATAI
CMPS
Tags
Small Cap
CMPS
Psychedelic/Assisted Therapies
From
Benzinga
Atai Launches Phase 1 Clinical Trial On Novel Direct-To-Brain Drug Delivery Technology
October 18, 2022
Tickers
ATAI
Tags
News
ATAI
Penny Stocks
From
Benzinga
Novel Psychedelic Compound Show Positive Results For Opioid Use Disorder Treatment
October 12, 2022
Tickers
ATAI
Tags
Psychedelics
Benzinga
opioid use disorder
From
Benzinga
Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report
August 15, 2022
Tickers
ATAI
HTGC
Tags
Psychedelics
Benzinga
Treatment Resistant Depression
From
Benzinga
Atai Life Sciences: Capital Raise, Share Options, Cathy Wood And More On Biotech Psychedelics Leader
July 07, 2022
Tickers
ATAI
Tags
Markets
Offerings
Market News
From
Benzinga
EXCLUSIVE: Atai Life Sciences Posts Earnings for Q1 2022, Advancing Key Milestones In Psychedelic Drug Development
May 16, 2022
Tickers
ATAI
Tags
News
ATAI
Exclusives
From
Benzinga
Can Ketamine For Depression Be Improved? New Study Will Looks Into Ketamine Analog Arketamine
September 14, 2021
Tickers
ATAI
JNJ
Tags
Florian Brand
Markets
Cannabis
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.